Novo Nordisk reports 2025 sales growth, cuts 2026 outlook
Go back to Novo Nordisk reports 2025 sales growth, cuts 2026 outlook| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 45.88 +2.69 (6.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.19 | 52 Week High | $59.00 | |||
| Open | $44.01 | 52 Week Low | $32.80 | |||
| Day High | $46.45 | P/E | N/A | |||
| Day Low | $43.90 | EPS | $0.00 | |||
| Volume | 17,050,026 | |||||

